Prelude Therapeutics PRLD
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 2.90 | -0.20 | -17,348 | -16 | ||
| 2025Q3 | 1.44 | -0.26 | -20,418 | -20 | ||
| 2025Q2 | 0.81 | 103.08 | -0.41 | -32,194 | -31 | |
| 2025Q1 | 0.77 | 107.86 | -0.42 | -34,606 | -32 | |
| 2024Q4 | 1.28 | 117.75 | -0.38 | -33,831 | -29 | |
| 2024Q3 | 2.07 | 106.52 | -0.43 | -34,376 | -32 | |
| 2024Q2 | 3.81 | 106.98 | -0.45 | -37,164 | -35 | |
| 2024Q1 | 4.74 | 109.26 | -0.42 | -34,343 | -31 | |
| 2023Q4 | 4.27 | 113.01 | -0.47 | -37,379 | -33 | |
| 2023Q3 | 3.09 | 109.07 | -0.43 | -33,385 | -31 | |
| 2023Q2 | 4.50 | 106.46 | -0.54 | -32,398 | -30 | |
| 2023Q1 | 5.70 | 105.04 | -0.58 | -29,115 | -28 | |
| 2022Q4 | 6.04 | 116.56 | -0.60 | -33,385 | -29 | |
| 2022Q3 | 6.61 | 101.50 | -0.64 | -30,406 | -30 | |
| 2022Q2 | 5.22 | 107.62 | -0.57 | -29,461 | -27 | |
| 2022Q1 | 6.90 | 102.79 | -0.63 | -30,288 | -29 | |
| 2021Q4 | 12.45 | 100.51 | -0.71 | -33,010 | -33 | |
| 2021Q3 | 31.25 | 100.49 | -0.66 | -30,836 | -31 | |
| 2021Q2 | 28.63 | 103.93 | -0.59 | -27,922 | -27 | |
| 2021Q1 | 43.33 | 103.13 | -0.47 | -21,967 | -21 |